top of page
​BioFinland Member

BioFinlandin jäsen

Faron Pharmaceuticals Ltd

Faron Pharmaceuticals Ltd
Yrityksen nimi

Faron Pharmaceuticals Ltd

Osoite

Joukahaisenkatu 6, FI-20520 Turku

Puhelin

+358 2 469 5151

Työntekijät

10-49

Perustettu

2003

Yhteyshenkilö

Virve Nurmi

toimitusjohtaja

Dr. Markku Jalkanen

Pääluokat

Drug Discovery and Development / Drug Delivery

Viimeksi päivitetty

21 February 2022

Yrityksen profiili

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs caused by dysfunction of our immune system. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology, organ damage and bone marrow regeneration.

Bexmarilimab, a novel anti-Clever-1 humanized antibody, is a precision immunotherapy with the potential to provide permanent immune stimulation for difficult-to-treat cancers through targeting myeloid function. Traumakine is an investigational intravenous (IV) interferon beta-1a therapy for the treatment of acute respiratory distress syndrome (ARDS) and other ischemic or hyperinflammatory conditions. Faron is based in Turku, Finland. Further information is available at www.faron.com.

bottom of page